• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Bio-Techne Corp (TECH)

Common Shares
Sell: $54.78|Buy: $56.28|Change: 0.03 (-0.05%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Address

614 McKinley Place N.E
Minneapolis
MN
USA
55413

Telephone

+1 646 2771266

Website

https://www.bio-techne.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Bio-Techne Corp Second Quarter Earnings Conference Call for 20272027-02-04T08:00:00
Bio-Techne Corp Second Quarter Earnings Results for 20272027-02-04T00:00:00
Bio-Techne Corp First Quarter Earnings Conference Call for 20272026-11-05T08:00:00
Bio-Techne Corp First Quarter Earnings Results for 20272026-11-05T00:00:00
Bio-Techne Corp Annual General Meeting for 20262026-10-30T08:00:00
Bio-Techne Corp Annual Report for 20262026-08-21T00:00:00
Bio-Techne Corp Fourth Quarter Earnings Conference Call for 20262026-08-06T08:00:00
Bio-Techne Corp Fourth Quarter Earnings Results for 20262026-08-06T00:00:00
Bio-Techne Corp Third Quarter Earnings Conference Call for 20262026-05-07T08:00:00
Bio-Techne Corp Third Quarter Earnings Results for 20262026-05-07T00:00:00

Previous key dates

NameKey Date
Leerink Partners Global Healthcare Conference2026-03-10T08:40:00
TD Cowen 46th Annual Health Care Conference2026-03-03T11:10:00
Bio-Techne Corp Second Quarter Earnings Conference Call for 20262026-02-04T08:00:00
Bio-Techne Corp Second Quarter Earnings Result for 20262026-02-04T00:00:00
J.P. Morgan Healthcare Conference2026-01-13T09:00:00
53rd Annual Nasdaq Investor Conference2025-12-09T04:30:00
Citi's 2025 Global Healthcare Conference2025-12-03T15:15:00
8th Annual Evercore Healthcare Conference 20252025-12-02T08:20:00
Jefferies Global Healthcare Conference2025-11-20T07:30:00
Stephens Investment Conference2025-11-18T08:00:00
Stifel 2025 Healthcare Conference2025-11-11T09:20:00
UBS Global Healthcare Conference 20252025-11-10T10:15:00
Bio-Techne Corp First Quarter Earnings Conference Call for 20262025-11-05T08:00:00
Bio-Techne Corp First Quarter Earnings Result for 20262025-11-05T00:00:00
Bio-Techne Corp Annual General Meeting for 20252025-10-30T08:00:00
Morgan Stanley 23rd Annual Global Healthcare Conference2025-09-10T10:45:00
Baird 2025 Global Healthcare Conference2025-09-09T09:05:00
2025 Wells Fargo Healthcare Conference2025-09-03T10:15:00
Bio-Techne Corp Annual Report for 20252025-08-22T00:00:00
Bio-Techne Corp Fourth Quarter Earnings Conference Call for 20252025-08-06T08:00:00
Bio-Techne Corp Fourth Quarter Earnings Result for 20252025-08-06T00:00:00
Goldman Sachs 46th Annual Global Healthcare Conference2025-06-10T10:40:00
Jefferies Global Healthcare Conference2025-06-04T15:45:00
William Blair 45th Annual Growth Stock Conference2025-06-03T14:20:00
BofA Securities 2025 Health Care Conference2025-05-13T10:40:00
Bio-Techne Corp Third Quarter Earnings Conference Call for 20252025-05-07T08:00:00
Bio-Techne Corp Third Quarter Earnings Results for 20252025-05-07T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.